Stocks/BBLG

Create a free account to see ACCE Scores

Sign up for free to unlock scores, score breakdowns, and stock analysis.

BBLG

↓ PDF (Pro)
Bone Biologics Corp Common Stock
HealthcareBiotechnologyUnited StatesNASDAQ
$1.32
-4.35%today
MKT CAP
$2M
+4.8% · 1Y
Earnings History
-129.3%
+69.9%
-85.3%
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$1.32
Low
$22.20
Analyst Mean
$22.20
High
$22.20
1 analystNone
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin0.0%
Operating Margin0.0%
Net Margin0.0%
ROE-70.2%
Debt / Equity-
Free Cash Flow$-1,650,181
Insider Ownership0.0%
Institutional Ownership2.7%
Short % of Float0.40%
Days to Cover0.6d
1 Week+0.0%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
HolderType% HeldValueΔ SharesAs of
DRW Securities, LLCinstitution1.31%$0.00B+113.80%2025-12-31
Two Sigma Investments, LPinstitution0.62%$0.00B+100.00%2025-12-31
Citadel Advisors Llcinstitution0.60%$0.00B+100.00%2025-12-31
Fidelity Concord Street Trust-Fidelity Extended Market Index Fundfund0.37%$0.00B+33.02%2026-02-28
Tower Research Capital LLC (TRC)institution0.19%$0.00B+130.81%2025-12-31
Fidelity Concord Street Trust-Fidelity Total Market Index Fundfund0.04%$0.00B+0.00%2026-03-31
Fidelity Concord Street Trust-Fidelity Series Total Market Index Fundfund0.03%$0.00B+0.00%2026-03-31
SBI Securities Co., Ltd.institution0.01%$0.00B+0.00%2026-03-31
Bank of America Corporationinstitution0.00%$0.00B+0.00%2025-12-31
UBS Group AGinstitution0.00%$0.00B-97.13%2026-03-31
TickerCapScoreP/EFwd P/EEV/EBITDAROEGrossD/EDiv
PTGX
Protagonist Therapeutics Inc. Common Stock
$6.6B5------0.00%
CELC
Celcuity Inc. Common Stock
$6.7B5------0.00%
ACLX
Arcellx Inc. Common Stock
$6.7B5-------
KYMR
Kymera Therapeutics Inc. Common Stock
$7.0B-----27.1%0%5.230.00%
TECH
Bio-Techne Corp Common Stock
$7.1B3672.724.4----63.00%
HALO
Halozyme Therapeutics Inc. Common Stock
$7.9B7325.56.6----0.00%
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Upgrade from $15/mo →
Recent Alerts
No alerts yet for BBLG.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →
Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.